Press "Enter" to skip to content

New patent for APGDI drug MYRBETRIQ

1
Copyright © DrugPatentWatch. Originally published at New patent for APGDI drug MYRBETRIQ

Annual Drug Patent Expirations for MYRBETRIQ
Annual Drug Patent Expirations for MYRBETRIQ

Myrbetriq is a drug marketed by Apgdi and is included in one NDA. It is available from three suppliers. There are seven patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for MYRBETRIQ.

This drug has one hundred and nine patent family members in twenty-nine countries.

The generic ingredient in MYRBETRIQ is mirabegron. Three suppliers are listed for this compound. Additional details are available on the mirabegron profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for APGDI drug MYRBETRIQ
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions